Azithromycin Clears Bordetella pertussis Infection in Mice but Also Modulates Innate and Adaptive Immune Responses and T Cell Memory

Lung CD4 Tissue-Resident Memory T Cells Mediate Adaptive Immunity Induced by Previous Infection of Mice withBordetella pertussis

(2017) Mieszko M. Wilk et al.   JOURNAL OF IMMUNOLOGY

Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial

(2017) Peter G Gibson et al.   LANCET

Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance

(2017) Dorji Dorji et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

InvestigatingBordetella pertussiscolonisation and immunity: protocol for an inpatient controlled human infection model

(2017) Hans de Graaf et al.   BMJ Open

Azithromycin modulates immune response of human monocyte-derived dendritic cells and CD4 + T cells

(2016) Syh-Jae Lin et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Short-Lived Antigen Recognition but Not Viral Infection at a Defined Checkpoint Programs Effector CD4 T Cells To Become Protective Memory

(2016) Bianca L. Bautista et al.   JOURNAL OF IMMUNOLOGY

Collateral Damage: Detrimental Effect of Antibiotics on the Development of Protective Immune Memory

(2016) Joseph M. Benoun et al.   mBio

Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury

(2015) Bei Zhang et al.   Journal of Neuroinflammation

T-cell immune responses toBordetella pertussisinfection and vaccination: Graphical Abstract Figure.

(2015) Giorgio Fedele et al.   Pathogens and Disease

Differential Kinetics of Antigen Dependency of CD4+ and CD8+ T Cells

(2014) H. Rabenstein et al.   JOURNAL OF IMMUNOLOGY

Long-term macrolide maintenance therapy in non-CF bronchiectasis: Evidence and questions

(2014) Charles S. Haworth et al.   RESPIRATORY MEDICINE

Azithromycin suppresses CD4+ T-cell activation by direct modulation of mTOR activity

(2014) F. Ratzinger et al.   Scientific Reports

Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin

(2013) F. R. MOOI et al.   EPIDEMIOLOGY AND INFECTION

Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine

(2013) Pádraig J. Ross et al.   PLoS Pathogens

Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates

(2012) J M Warfel et al.   Mucosal Immunology

Immunity to the respiratory pathogen Bordetella pertussis

(2012) R Higgs et al.   Mucosal Immunology

Differential Expression of Alpha 4 Integrins on Effector Memory T Helper Cells during Bordetella Infections. Delayed Responses in Bordetella pertussis

(2012) Tuan M. Nguyen et al.   PLoS One

Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophagesin chronic obstructive pulmonary disease subjects

(2012) SANDRA HODGE et al.   RESPIROLOGY

Quantifying Antigen-Specific CD4 T Cells during a Viral Infection: CD4 T Cell Responses Are Larger Than We Think

(2011) D. S. McDermott et al.   JOURNAL OF IMMUNOLOGY

Azithromycin Alters Macrophage Phenotype and Pulmonary Compartmentalization during Lung Infection with Pseudomonas

(2010) D. J. Feola et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Early Infection Termination Affects Number of CD8+ Memory T Cells and Protective Capacities in Listeria monocytogenes-Infected Mice upon Rechallenge

(2009) K.-E. Tseng et al.   JOURNAL OF IMMUNOLOGY